Standout Papers

KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Ov... 2021 2026 2022 2024158
  1. KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments (2021)
    T. Koga, Kenichi Suda et al. Journal of Thoracic Oncology

Immediate Impact

1 by Nobel laureates 63 standout
Sub-graph 1 of 22

Citing Papers

Digestive cancers: mechanisms, therapeutics and management
2025 Standout
Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways
2025 Standout
2 intermediate papers

Works of Akira Hamada being referenced

KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments
2021 Standout

Author Peers

Author Last Decade Papers Cites
Akira Hamada 363 75 195 158 62 546
Guangxi Sun 327 111 173 148 82 577
Jiun‐Yi Hsia 244 169 153 208 38 585
Yoshimi Otani 289 127 158 180 39 619
Subir Goyal 200 85 228 118 63 518
Matteo Perrino 355 37 163 136 47 638
H Kanamaru 234 119 146 134 35 508
Nalan Akgül Babacan 166 81 295 99 50 529
Yoshimasa Nakazato 257 113 133 84 69 527
Qiuning Zhang 222 67 167 173 67 538
Alessandra Maleddu 273 89 161 150 27 536

All Works

Loading papers...

Rankless by CCL
2026